Skip to content

Quick ratio at other companies

CVS Health logo
CVS HealthCVS
0.7×0.0×
UnitedHealth Group logo
UnitedHealth GroupUNH
0.8×-0.1×
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
1.2×-0.4×
Astrana Health logo
Astrana HealthASTH
1.3×-0.4×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
1.4×0.0×
Elevance Health logo
Elevance HealthELV
1.5×0.0×

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Calculated from Evolent Health, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s quick ratio?
Evolent Health, Inc. (EVH) reported quick ratio of 1.3× in Q1 2026.
How has Evolent Health, Inc.'s quick ratio changed year-over-year?
Evolent Health, Inc.'s quick ratio increased by 33.7% year-over-year, from 1× to 1.3×.
What is the long-term trend for Evolent Health, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Evolent Health, Inc.'s quick ratio has grown at a -0.6% compound annual growth rate (CAGR), from 1.4× to 1.3×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.